false Q2 2025 --06-30 0001616788 0001616788 2024-07-01 2024-12-31 0001616788 2025-05-08 0001616788 2024-12-31 0001616788 2024-06-30 0001616788 srt:DirectorMember 2024-12-31 0001616788 srt:DirectorMember 2024-06-30 0001616788 us-gaap:MajorityShareholderMember 2024-12-31 0001616788 us-gaap:MajorityShareholderMember 2024-06-30 0001616788 2024-10-01 2024-12-31 0001616788 2023-10-01 2023-12-31 0001616788 2023-07-01 2023-12-31 0001616788 us-gaap:CommonStockMember 2023-06-30 0001616788 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001616788 us-gaap:RetainedEarningsMember 2023-06-30 0001616788 2023-06-30 0001616788 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001616788 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001616788 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001616788 2023-07-01 2023-09-30 0001616788 us-gaap:CommonStockMember 2023-09-30 0001616788 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001616788 us-gaap:RetainedEarningsMember 2023-09-30 0001616788 2023-09-30 0001616788 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001616788 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001616788 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001616788 us-gaap:CommonStockMember 2023-12-31 0001616788 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001616788 us-gaap:RetainedEarningsMember 2023-12-31 0001616788 2023-12-31 0001616788 us-gaap:CommonStockMember 2024-06-30 0001616788 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001616788 us-gaap:RetainedEarningsMember 2024-06-30 0001616788 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001616788 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001616788 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001616788 2024-07-01 2024-09-30 0001616788 us-gaap:CommonStockMember 2024-09-30 0001616788 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001616788 us-gaap:RetainedEarningsMember 2024-09-30 0001616788 2024-09-30 0001616788 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001616788 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001616788 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001616788 us-gaap:CommonStockMember 2024-12-31 0001616788 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001616788 us-gaap:RetainedEarningsMember 2024-12-31 0001616788 2023-12-27 2023-12-27 0001616788 LGYV:EverGreenLivingVenturesMember 2023-12-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2024

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to ______

Commission File Number 000-55849

LEGACY VENTURES INTERNATIONAL, INC

(Exact name of registrant as specified in its charter)

Nevada

30-0826318

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

Unit 01, 82/F. International Commerce Centre, 1 Austin Road West, Kowloon, Hong Kong 00000

(Address of principal executive offices) (Zip Code)

+852 3960 6394

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company”, in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☒
(Do not check if smaller reporting company)	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name on each exchange on which registered
N/A		N/A		N/A

As of May 8, 2025, there were 50,315,064 outstanding shares of the registrant’s common stock, $0.0001 par value per share

TABLE OF CONTENTS

	Page No.
PART I – FINANCIAL INFORMATION

Item 1. Financial Statements	3

Item 2. Management’s Discussion and Analysis	10

Item 3. Quantitative and Qualitative Disclosures About Market Risk	11

Item 4. Controls and Procedures	11

PART II – OTHER INFORMATION

Item 1. Legal Proceedings	12

Item 1A. Risk Factors	12

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	12

Item 3. Defaults Upon Senior Securities	12

Item 4. Mine Safety Disclosures	12

Item 5. Other Information	12

Item 6. Exhibits	12

PART I

FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS REQUIRED BY FORM 10-Q

The Interim Condensed Consolidated Financial Statements of the Company are prepared as of December 31, 2024

CONTENTS

Interim Condensed Consolidated Balance Sheets	4

Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)	5

Interim Condensed Consolidated Statements of Stockholders’ Deficiency	6

Interim Condensed Consolidated Statements of Cash Flows	7

Notes to the Interim Condensed Consolidated Financial Statements	8

LEGACY VENTURES INTERNATIONAL, INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

(Express in United States Dollars (“US dollars”), except for number of shares)

	Note	December 31, 2024			June 30, 2024
ASSETS
Current assets
Cash		$	983		$	842
Total assets		$	983		$	842

LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current liabilities
Accounts payable and accrued liabilities	4	$	14,244		$	31,904
Amount due to a director	4		1,282			1,282
Advances from a shareholder	4		166,519			104,525
Total liabilities		$	182,045		$	137,711

Stockholders’ deficiency
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized: Preferred Stock – no shares issued and outstanding December 31, 2024, and June 30, 2024	6	$	-		$	-
Common Stock, $0.0001 par value; 100,000,000 shares authorized: Common Stock – 50,315,064 shares issued and outstanding December 31, 2024 and June 30, 2024	6		5,032			5,032
Additional paid in capital			6,429,771			6,429,771
Accumulated deficit			(6,615,865	)		(6,571,672	)
Total stockholders’ deficiency			(181,062	)		(136,869	)
Total liabilities and stockholders’ deficiency		$	983		$	842

Going Concern	2
Subsequent events	7

See accompanying notes to the unaudited interim condensed consolidated financial statements

LEGACY VENTURES INTERNATIONAL, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(unaudited)

(Express in United States Dollars (“US dollars”), except for number of shares)


		For the three months ended December 31,						For the six months ended December 31,
	Note	2024			2023			2024			2023
Operating expenses
Professional fees		$	22,890		$	5,500		$	42,632		$	11,000
Other general and administration expenses			833			5,268			1,562			6,512
Loss from operations			(23,723	)		(10,768	)		(44,194	)		(17,512	)
Other income
Interest income			1			-			1			-
Total other income			1			-			1			-
Loss before taxes			(23,722	)		(10,768	)		(44,193	)		(17,512	)
Net loss and comprehensive loss		$	(23,722	)	$	(10,768	)	$	(44,193	)	$	(17,512	)

Net loss per share - basic and diluted	5	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Weighted average number of common shares outstanding – basic and diluted			50,315,064			50,315,064			50,315,064			50,315,064

See accompanying notes to the unaudited interim condensed consolidated financial statements

LEGACY VENTURES INTERNATIONAL, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY

(unaudited)

(Express in United States Dollars (“US dollars”), except for number of shares)

For the six months ended December 31, 2023


		Common Stock				Additional
	Note	Number of Shares		Amount		paid in capital		Deficit			Total
June 30, 2023			50,315,064	$	5,032	$	6,429,771	$	(6,507,386	)	$	(72,583	)
Net loss			-		-		-		(6,744	)		(6,744	)
September 30, 2023			50,315,064	$	5,032	$	6,429,771	$	(6,514,130	)	$	(79,327	)
Net loss			-		-		-		(10,768	)		(10,768	)
December 31, 2023			50,315,064	$	5,032	$	6,429,771	$	(6,524,898	)	$	(90,095	)

For the six months ended December 31, 2024

		Common Stock				Additional
	Note	Number of Shares		Amount		paid in capital		Deficit			Total
June 30, 2024			50,315,064	$	5,032	$	6,429,771	$	(6,571,672	)	$	(136,869	)
Net loss			-		-		-		(20,471	)		(20,471	)
September 30, 2024			50,315,064	$	5,032	$	6,429,771	$	(6,592,143	)	$	(157,340	)
Balance			50,315,064	$	5,032	$	6,429,771	$	(6,592,143	)	$	(157,340	)
Net loss			-		-		-		(23,722	)		(23,722	)
December 31, 2024			50,315,064	$	5,032	$	6,429,771	$	(6,615,865	)	$	(181,062	)
Balance			50,315,064	$	5,032	$	6,429,771	$	(6,615,865	)	$	(181,062	)

See accompanying notes to the unaudited interim condensed consolidated financial statements

LEGACY VENTURES INTERNATIONAL, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(Express in United States Dollars (“US dollars”), except for number of shares)


	For the six months ended December 31,
	2024			2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(44,193	)	$	(17,512	)

Changes in non-cash operating assets and liabilities
Accounts payable and accrued liabilities		(17,660	)		(24,571	)
Net cash flows used in operating activities		(61,853	)		(42,083	)

CASH FLOWS FROM FINANCING ACTIVITY:
Advances from a shareholder		61,994			41,247
Net cash flows provided by financing activity		61,994			41,247

Decrease in cash		141			(836	)
Cash, beginning of period		842			1,678
Cash, end of period	$	983		$	842

Cash payments for:
Interest	$	-		$	-
Income taxes	$	-		$	-

See accompanying notes to the unaudited interim condensed consolidated financial statements

LEGACY VENTURES INTERNATIONAL, INC.

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(Express in United States Dollars (“US dollars”), except for number of shares)

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

Legacy Ventures International, Inc. (“Legacy” or the “Company”), was incorporated on March 4, 2014 under the laws of the State of Nevada. The Company currently has no ongoing operations except for the incurring of general and administrative expenditures.

On December 27, 2023, the Company incorporate Ever Green Living Ventures Ltd, a company incorporated in Hong Kong, with incorporation fee of $1,410. The Company owns 100% of Ever Green Living Ventures Ltd. The Company plans to engage in Biotech research & development and health care research & development through its wholly owned subsidiary in Hong Kong.

NOTE 2 – GOING CONCERN AND BASIS OF PRESENTATION

The Company’s unaudited interim condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As of December 31, 2024, the Company has a working capital deficiency of $181,062 (June 30, 2024 - $136,869), and an accumulated deficit of $6,615,865 (June 30, 2024 - $6,571,672). The Company’s continued existence is dependent upon its ability to continue to execute its operating plan, to obtain additional debt or equity financing, and to obtain continuing financial support of the shareholders. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. There can be no assurance that the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company, in which case the Company may be unable to meet its obligations. Should the Company be unable to realize its assets and discharge its liabilities in the normal course of business, the net realizable value of its assets may be materially less than the amounts recorded in the audited financial statements. The audited financial statements do not include any adjustments relating to the recoverability of recorded asset amounts that might be necessary should the Company be unable to continue in existence.

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS

SIGNIFICANT ACCOUNTING POLICIES

The Company’s significant accounting policies have not changed from the year ended June 30, 2024.

The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10–Q and Rule 10 of Regulation S–X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these unaudited condensed consolidated interim financial statements. These unaudited condensed consolidated interim financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2024, as filed with the SEC on November 27, 2024. Operating results for the six months ended December 31, 2024, are not necessarily indicative of the results that may be expected for any subsequent quarter or for the year ending June 30, 2025.

LEGACY VENTURES INTERNATIONAL, INC.

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US dollars)

(Unaudited)

NOTE 4 – RELATED PARTY ADVANCES AND BALANCES, AND ADVANCES FROM THIRD PARTIES

For the six months ended December 31, 2024, there is an advance from a shareholder of $61,994. The Company was advanced funds by a shareholder. The funds were used to pay certain professional fees including auditors and consultants. As of December 31, 2024 and June 30, 2024, there were a balance of $166,519 and $104,525 due to the shareholder, respectively. The balance is non-interest bearing and due on demand.

As of December 31, 2024 and June 30, 2024, there were a balance of $1,282 and $1,282 due to the director, respectively. The balance is non-interest bearing and due on demand.

NOTE 5 - BASIC AND DILUTED NET INCOME (LOSS) PER SHARE

The Company follows ASC Topic 260 to account for the income (loss) per share. Basic income (loss) per common share (“EPS”) calculations are determined by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per common share calculations are determined by dividing net loss by the weighted average number of common shares and dilutive common share equivalents (if dilutive) outstanding. All dilutive common share equivalents were anti-dilutive for the six months ended December 31, 2024 and 2023.

NOTE 6 - COMMON AND PREFERRED STOCK TRANSACTIONS

As of December 31, 2024, the Company was authorized to issue 10,000,000 of preferred stock, with a par value of $0.0001 and 100,000,000 of common stock, with a par value of $0.0001.

There was no common stock transactions for the six months ended December 31, 2024 and 2023.

As of December 31, 2024, and June 30, 2024, the Company had 50,315,064 common stock issued and outstanding.

NOTE 7 - SUBSEQUENT EVENTS

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2024 up through the date the Company issued the financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

This report contains forward-looking statements that involve risks and uncertainties. We use words such as anticipate, believe, plan, expect, future, intend and similar expressions to identify such forward-looking statements. You should not place too much reliance on these forward-looking statements. The Company’s actual results are likely to differ materially from those anticipated in these forward-looking statements for many reasons.

Plan of Operation

On December 27, 2023, the Company incorporate Ever Green Living Ventures Ltd, a company incorporated in Hong Kong. The Company owns 100% of Ever Green Living Ventures Ltd. The Company plans to engage in Biotech research & development and health care research & development through its wholly owned subsidiary in Hong Kong.

Liquidity and Capital Resources

As of December 31, 2024, the Company’s primary source of liquidity consisted of $983 (June 30, 2024 - $842) in cash. The Company financed its operations through a combination of advances from a shareholder and a director.

The Company has sustained net losses which have resulted in a total stockholders’ deficiency at December 31, 2024, and is currently experiencing a shortfall in operating capital which raises substantial doubt about the Company’s ability to continue as a going concern. The Company anticipates a net loss for the period ending December 31, 2024 and with the expected cash requirements for the coming months, without additional cash inflows from a corporate transaction or continuing financial support of the shareholders, there is substantial doubt as to the Company’s ability to continue operations.

We may seek to secure additional debt or equity capital to finance substantial business development initiatives. There is presently no agreement in place with any source of financing for the Company and there can be no assurance that the Company will be able to raise any additional funds, or that such funds will be available on acceptable terms. Funds raised through future equity financing will likely be substantially dilutive to current shareholders. Lack of additional funds will materially affect the Company and its business, and may cause the Company to cease operations. Consequently, shareholders could incur a loss of their entire investment in the Company.

Net Cash Used in Operating Activities

During the six months ended December 31, 2024, cash used in operations was $61,853 and $42,083 for the six months ended December 31, 2023, respectively. Cash used in operating activities was primarily the result of net loss from operations and settlement of accrual liabilities.

Net Cash Used in Investing Activities

There was no cash used in or provided by investing activities for the six months ended December 31, 2024 and 2023.

Net Cash Provided by Financing Activity

There was cash provided by financing activities of $61,994 and $41,247, respectively for the six months ended December 31, 2024 and 2023, as a result of the advances from a shareholder.

Results of Operations

For the three months ended December 31, 2024

Operating expenses. Operating expenses for the three months ended December 31, 2024, was $23,723 compared with $10,768 for the three months ended December 31, 2023. Operating expenses were similar in both period which arise from professional fee charged by auditor, consultant, edgar agent and transfer agent.

Other income (expenses). There was other income of $1 for the three months ended December 31, 2024, compared with no other income for the three months ended December 31, 2023.

Net loss. Net loss for the three months ended December 31, 2024, was $23,722, compared with net loss of $10,768 for the three months ended December 31, 2023.

For the six months ended December 31, 2024

Operating expenses. Operating expenses for the six months ended December 31, 2024, was $44,194 compared with $17,512 for the six months ended December 31, 2023. Operating expenses were similar in both period which arise from professional fee charged by auditor, consultant, edgar agent and transfer agent.

Other income (expenses). There was other income of $1 for the six months ended December 31, 2024, compared with no other income for the six months ended December 31, 2023.

Net loss. Net loss for the six months ended December 31, 2024, was $44,193, compared with net loss of $17,512 for the three months ended December 31, 2023.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Personnel

The Company has no full-time employees, but utilizes other project-based contract personnel to carry out the Company’s business. We utilize contract personnel on a continuous basis, primarily in connection with the filing of reports with the Securities and Exchange Commission which require a high level of specialization for one or more of the service components offered.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not Required.

Item 4. Controls and Procedures.

The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean a Company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC’s rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure.

As of the end of the period covered by this Quarterly Report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s chief executive officer and chief financial officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(b) and 15d-15(b). Based upon this evaluation, the Company’s chief executive officer and chief financial officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this Quarterly Report were ineffective due to a lack of segregation of duties, due to limited administrative and financial personnel and related resources and as the Company only has one director.

Changes in Internal Control over Financial Reporting

There have been no significant changes in the Company’s internal controls over financial reporting that occurred during the period ended December 31, 2024, that have materially or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

We are not currently subject to any legal proceedings, and to the best of our knowledge, no such proceeding is threatened, the results of which would have a material impact on the Company’s properties, results of operations, or financial condition. Nor, to the best of our knowledge, are any of the Company’s officers or directors involved in any legal proceedings in which we are an adverse party.

Item 1A. Risk Factors

Since we are a smaller reporting company, we are not required to provide the information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

The following exhibits are filed with or incorporated by reference in this report:

Item No.		Description

31.1*		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Dr. Seung Fai WONG.

32.1*		Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Dr. Seung Fai WONG.

101*		Inline XBRL Report

101.INS*		Inline XBRL Instance Document

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*		Cover Page Interactive Data File (embedded within the Inline XBRL document)

* filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	LEGACY VENTURES INTERNATIONAL, INC.

Date: May 8, 2025	By:	/s/ Dr. Seung Fai WONG
	Name:	Dr. Seung Fai WONG
	Title:	Chief Executive Officer, Chief Financial Officer

LEGACY VENTURES INTERNATIONAL INC. 10-Q